Medicament composition for treating pulmonary fibrosis

A technology of pulmonary fibrosis and composition, applied in the field of pharmaceutical composition for the treatment of pulmonary fibrosis, can solve the problems of lack of specific treatment, large toxic and side effects of chemical preparations, changes in fibrosis, etc., achieve small side effects, significant clinical curative effect, good safety effect

Inactive Publication Date: 2011-10-26
CHENGDU UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF2 Cites 17 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In terms of treatment, the current treatment of pulmonary fibrosis is limited to "stupid methods" such as non-specific anti-inflammation, immunosuppressants and glucocorticoids. Their common feature is the lack of specific treatment, and the extensive use of antibiotics and hormones is causing tissue and organ damage. An im

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicament composition for treating pulmonary fibrosis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] The preparation of embodiment 1 pharmaceutical composition of the present invention

[0020] Take 15 grams of ginseng, 15 grams of salvia miltiorrhiza, 11 grams of angelica, 15 grams of sealwort, 15 grams of perilla seed, 11 grams of white mustard seed, 11 grams of citrus aurantium, and 15 grams of low ground tea, which are processed by conventional extraction and purification methods, and then made into Drugs in the required dosage form, such as: granules, tablets, hard capsules, oral liquids, soft capsules, dripping pills or syrup.

Embodiment 2

[0021] The preparation of embodiment 2 pharmaceutical compositions of the present invention

[0022] Take 15 grams of ginseng, 15 grams of salvia miltiorrhiza, 11 grams of angelica, 15 grams of sealwort, 15 grams of perilla seed, 11 grams of white mustard seed, 11 grams of citrus aurantium, and 15 grams of low ground tea, which are processed by conventional extraction and purification methods, and then made into Drugs in the required dosage form, such as: granules, tablets, hard capsules, oral liquids, soft capsules, dripping pills or syrup.

Embodiment 3

[0023] The preparation of embodiment 3 pharmaceutical composition of the present invention

[0024] Take 7 grams of ginseng, 7 grams of salvia miltiorrhiza, 3 grams of angelica, 7 grams of Polygonatum, 7 grams of perilla seed, 3 grams of white mustard seed, 3 grams of citrus aurantium, and 7 grams of low ground tea, which are processed by conventional extraction and purification methods, and then made into Drugs in the required dosage form, such as: granules, tablets, hard capsules, oral liquids, soft capsules, dripping pills or syrup.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a medicament composition for treating pulmonary fibrosis. The medicament composition comprises the following active pharmaceutical ingredients by weight: 5-15 parts of ginseng, 5-15 parts of danshen root, 1-11 parts of angelica, 5-15 parts of manyflower solomonseal rhizome, 5-15 parts of perilla frutescens, 1-11 parts of brassica alba boiss, 1-11 parts of fructus aurantii immaturus and 5-15 parts of Japanese ardisia herb. The invention also provides a preparation method of the composition and application of the composition to preparing the medicaments for treating pulmonary fibrosis. The chemical fiber No.1 medicament composition provided by the invention has the effect of inhibiting proliferation of human embryo lung diploid fibroblasts (2BS), can be used for preparing the medicaments for treating pulmonary fibrosis, has obvious clinical effect, minimal side effect and good safety and provides a new choice for clinically treating pulmonary fibrosis.

Description

technical field [0001] The invention relates to the field of medicines, in particular to a medicine composition for treating pulmonary fibrosis. Background technique [0002] Hu Zhuowei, a well-known authoritative scholar who has studied tissue and organ fibrosis for a long time, pointed out: "The latest research in the international medical community shows that all organs and tissues in the human body may have fibrosis. Many chronic diseases directly lead to fibrosis of organs and tissues. Fibrosis is a chronic disease. The root cause of long-term cure, which involves almost all organs and systems of the human body, is the main cause of disability and death in many diseases, and seriously threatens human health and life. Only by eradicating the root cause of chronic diseases - fibrosis, can chronic diseases be completely disintegrated. The dangers of stubborn diseases to human beings." [0003] Pulmonary fibrosis (PF) is the most representative, most typical and most frequ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8969A61P11/00
Inventor 李戎闫智勇
Owner CHENGDU UNIV OF TRADITIONAL CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap